DK272083A - Oxazoleddikesyrederivater - Google Patents

Oxazoleddikesyrederivater Download PDF

Info

Publication number
DK272083A
DK272083A DK272083A DK272083A DK272083A DK 272083 A DK272083 A DK 272083A DK 272083 A DK272083 A DK 272083A DK 272083 A DK272083 A DK 272083A DK 272083 A DK272083 A DK 272083A
Authority
DK
Denmark
Prior art keywords
oxazoledicacic
acid derivatives
derivatives
acid
oxazoledicacic acid
Prior art date
Application number
DK272083A
Other languages
English (en)
Other versions
DK272083D0 (da
Inventor
Kanji Meguro
Takeshi Fujita
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of DK272083D0 publication Critical patent/DK272083D0/da
Publication of DK272083A publication Critical patent/DK272083A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/36—One oxygen atom
    • C07D263/40—One oxygen atom attached in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK272083A 1982-06-15 1983-06-14 Oxazoleddikesyrederivater DK272083A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP57103544A JPS58219169A (ja) 1982-06-15 1982-06-15 オキサゾ−ル酢酸誘導体

Publications (2)

Publication Number Publication Date
DK272083D0 DK272083D0 (da) 1983-06-14
DK272083A true DK272083A (da) 1983-12-16

Family

ID=14356777

Family Applications (1)

Application Number Title Priority Date Filing Date
DK272083A DK272083A (da) 1982-06-15 1983-06-14 Oxazoleddikesyrederivater

Country Status (15)

Country Link
US (1) US4602027A (da)
EP (1) EP0096890B1 (da)
JP (1) JPS58219169A (da)
KR (1) KR840005116A (da)
AU (1) AU1565783A (da)
CA (1) CA1195986A (da)
DE (1) DE3374685D1 (da)
DK (1) DK272083A (da)
ES (2) ES523152A0 (da)
FI (1) FI832036L (da)
GR (1) GR78290B (da)
HU (1) HU189296B (da)
NO (1) NO832146L (da)
PT (1) PT76871B (da)
ZA (1) ZA834307B (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8531608D0 (en) * 1985-12-23 1986-02-05 Beecham Group Plc Treatment
US5239080A (en) * 1989-02-08 1993-08-24 Takeda Chemical Industries, Ltd. Oxazole compounds and their use as antidiabetic and bone-reduction inhibitory agents
EP0409418A1 (en) * 1989-07-20 1991-01-23 Imperial Chemical Industries Plc Heterocyclic tertiary alcohols
EP0440183A1 (en) * 1990-02-01 1991-08-07 Takeda Chemical Industries, Ltd. Oxazole compounds, their production and use
TW311136B (da) 1990-11-30 1997-07-21 Otsuka Pharma Co Ltd
WO1994001433A1 (en) * 1992-07-13 1994-01-20 Japan Tobacco Inc. Novel thiazolidinedione compound and use thereof
MY128323A (en) 1996-09-30 2007-01-31 Otsuka Pharma Co Ltd Thiazole derivatives for inhibition of cytokine production and of cell adhesion
CN1235887C (zh) 1998-03-30 2006-01-11 日本烟草产业株式会社 噁唑基乙醇衍生物的制备方法
CA2383524C (en) * 1999-08-31 2010-09-28 Merck & Co., Inc. Thiazolyl alkynyl compounds and methods of use thereof
KR100459917B1 (ko) * 2001-12-14 2004-12-03 (주)바이오뉴트리젠 페놀릭산 유도체 및 이를 포함하는 혈중 지질 농도 관련질환의 예방 및 치료용 조성물

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3401120A (en) * 1965-10-23 1968-09-10 Gaf Corp Corrosion inhibitors
FI53314C (fi) * 1967-06-14 1978-04-10 Wyeth John & Brother Ltd Foerfarande foer framstaellning av farmaceutiskt anvaendbar 2-(fenyleller p-klorfenyl) oxazol-4-yl (aettiksyra -acetatsalt eller -acetamid)
GB1245087A (en) * 1967-10-26 1971-09-02 Wyeth John & Brother Ltd Heterocyclic compounds
US3578671A (en) * 1967-11-06 1971-05-11 Wyeth John & Brother Ltd Oxazoles
AR208400A1 (es) * 1974-03-13 1976-12-27 Yoshitomi Pharmaceutical Un metodo para producir nuevos acidos 5-alcoxi-4-oxazolalcanoicos 2-substituidos y sus esteres
JPS57188587A (en) * 1981-05-15 1982-11-19 Tanabe Seiyaku Co Ltd Thienyloxazolylacetic acid derivative and its preparation

Also Published As

Publication number Publication date
JPS58219169A (ja) 1983-12-20
FI832036A0 (fi) 1983-06-07
KR840005116A (ko) 1984-11-03
HU189296B (en) 1986-06-30
GR78290B (da) 1984-09-26
CA1195986A (en) 1985-10-29
PT76871A (en) 1983-07-01
ZA834307B (en) 1984-03-28
ES8600751A1 (es) 1985-11-01
ES538030A0 (es) 1985-11-01
DE3374685D1 (en) 1988-01-07
EP0096890A3 (en) 1984-11-14
PT76871B (en) 1986-01-27
ES8503676A1 (es) 1985-04-01
FI832036L (fi) 1983-12-16
EP0096890B1 (en) 1987-11-25
DK272083D0 (da) 1983-06-14
ES523152A0 (es) 1985-04-01
NO832146L (no) 1983-12-16
JPH044312B2 (da) 1992-01-27
EP0096890A2 (en) 1983-12-28
US4602027A (en) 1986-07-22
AU1565783A (en) 1983-12-22

Similar Documents

Publication Publication Date Title
DE3368052D1 (de) 4-chloro-2-phenylimidazole-5-acetic acid derivatives
DE3371513D1 (de) Propynylaminoisoxazole derivatives
DE3372768D1 (de) 1-sulfo-2-oxoazetidine derivatives
FI820776L (fi) Pressparti i pappersmaskin
ATE34383T1 (de) Oxamidsaeure-derivate.
BR8307281A (pt) Derivados de pirazolina
DE3361894D1 (de) Aminocarboxylic acid derivatives
DE3371906D1 (de) Deazapurine derivatives
DE3369990D1 (de) Methylflavone derivatives
DK272083D0 (da) Oxazoleddikesyrederivater
DE3364323D1 (de) Phenoxypropanolamine derivatives
DK587283D0 (da) Propynylaminothiazolderivater
DE3483294D1 (de) Barbitursaeurederivate.
DE3360053D1 (de) 3-benzoyl-2-mercaptopropionic acid derivatives
DK617084D0 (da) Prostatriensyrederivater
IT1194339B (it) Carbapenem-derivati fluoroalchilati
DK340485D0 (da) Phenylnonatetraensyrederivater
DK12783A (da) Phenylureaderivater
DK155731C (da) 3-brom-4-fluor-benzoesyreamid
DK317985D0 (da) Aminoeburnancarboxylsyrederivater
DE3376832D1 (de) Acridanone derivatives
DK568383D0 (da) N-alkyl-piperidinylbenzoatderivater
DK318085A (da) Nitroapovincaminsyrederivater
DE3467164D1 (de) Pyrrole-2-acetylamino acid derivatives
DE3364219D1 (de) Novel 6-bromocholesterol derivatives

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment